DRUG2DRUGS
LIVE

Serial Number

88418801

Owner

FUJIFILM CORPORATION

Attorney

Suzanne M. Hengl

Filing Date

May 7, 2019

Add to watchlist:

No watchlists yet
View on USPTO

DRUG2DRUGS Trademark

Serial Number: 88418801 • Registration: 7135187

DRUG2DRUGS is a trademark filed by FUJIFILM CORPORATION on May 7, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

FUJIFILM CORPORATION (529 trademarks)

26-30, NISHIAZABU 2-CHOME, MINATO-KU
TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

May 7, 2019

Registration Date

August 15, 2023

Published for Opposition

July 7, 2020

Goods & Services

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Chemical additives for use in the manufacture of pharmaceuticals; chemicals and chemical preparations for use in the manufacture of pharmaceuticals; chemicals and chemical preparations for use in scientific and biotechnological research and development

Providing medical information relating to diagnostic, prevention and healing property of medicines; providing medical information relating to pharmaceuticals and compounds which is a source of pharmaceuticals; providing health information; dietary and nutritional guidance; rental of medical machines and apparatus; pharmaceutical compounding services

Development of pharmaceutical preparations and medicines; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Testing of pharmaceuticals; design, development and research of chemicals, pharmaceuticals and chemical compounds; consultancy and information services relating to design, development and research of chemicals, pharmaceuticals and chemical compounds; analysis, testing and inspection of chemicals, pharmaceuticals and chemical compounds; consultancy and information services relating to analysis, testing and inspection of chemicals, pharmaceuticals and chemical compounds; pharmaceutical drug development services; Technical research in the field of pharmaceutical studies; research on the subject of pharmaceuticals; pharmaceutical research services; consulting services in the field of pharmaceutical research; testing, inspection or research of pharmaceuticals; pharmaceutical research and development; research of molecule design; consultancy and information services relating to research of molecule design; scientific research and testing surveys in the nature of research on the subject of pharmaceuticals, pharmaceutical research and development and pharmaceutical drug development services; providing computer programs, namely, providing on-line non-downloadable software for design, development and research of compounds which are a source of pharmaceuticals in the field of development of new drugs; designing of machines, apparatus, instruments or systems composed of such machines, apparatus and instruments; rental of laboratory apparatus and instruments

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 15, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 15, 2023 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Jul 13, 2023 DP1B
NOTICE OF ALLOWANCE CANCELLED
Jun 28, 2023 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Jun 28, 2023 D1BR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 13, 2023 EXRA
SOU EXTENSION 5 GRANTED
Jan 12, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 12, 2023 AITU
SOU EXTENSION 5 FILED
Dec 28, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 28, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 20, 2022 EXRA
SOU EXTENSION 4 GRANTED
Aug 18, 2022 EX4G
SOU EXTENSION 4 FILED
Aug 18, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 18, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 22, 2022 EXRA
SOU EXTENSION 3 GRANTED
Jan 20, 2022 EX3G
SOU EXTENSION 3 FILED
Jan 20, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 20, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 16, 2021 EXRA
SOU EXTENSION 2 GRANTED
Jul 14, 2021 EX2G
SOU EXTENSION 2 FILED
Jul 14, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 14, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 21, 2020 EXRA
SOU EXTENSION 1 GRANTED
Oct 19, 2020 EX1G
SOU EXTENSION 1 FILED
Oct 19, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 19, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 1, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 7, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 17, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 1, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 29, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 29, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 27, 2020 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 2, 2020 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 2, 2020 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 2, 2020 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 27, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 27, 2019 GNSL
SUSPENSION LETTER WRITTEN
Aug 27, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 27, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 27, 2019 CRFA
ASSIGNED TO LIE
Aug 23, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 14, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 17, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jun 17, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jun 17, 2019 CNRT
ASSIGNED TO EXAMINER
Jun 17, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 22, 2019 NWOS
NEW APPLICATION ENTERED
May 10, 2019 NWAP